SS Innovations International, Inc. (SSII): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
SS Innovations International, Inc. (SSII) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 SS Innovations Strengthens Management Team in Preparation for Global Sales Expansion Promotes Dr. Vishwa Srivastava to President and Appoints Gary Lo as Chief Financial Officer FORT LAUDERDALE, Fla. – November 13, 2026 – SS Innovations International, Inc. (the “Compa
- Person
- Vishwa Srivastava
- Title
- President
- Action
- promoted
- Predecessor
- Chief Executive Officer – Asia Pacific
Facts are quoted from the filing text and checked against it. Details that could not be matched to the text are left out.
How this was made
The 30-second read
Why it matters
The executive changes are routine corporate governance updates with minimal immediate price effect.
Market read
Primary disclosure of executive appointments; low trading relevance.
What to watch
Potential impact of FDA 510(k) review progress and CE marking timeline on future revenue.
Background
SS Innovations International develops affordable surgical robotic systems and is expanding globally. The 8‑K filing announces senior management changes.
Ticker impact
SEC Form 8‑K reports promotion of Dr. Vishwa Srivastava to President and appointment of Gary Lo as CFO, a new executive change for SS Innovations.
likely neutral as investors assess leadership transition
The filing provides no financial numbers or strategic deals; market impact is typically limited for mid‑cap exec changes.
Market effects
None significant; the robotic surgery sector sees no new product or regulatory event.
Limited to US investors tracking Nasdaq micro‑caps.
Low; no broader market or macro implications.
Counterpoint
If the new leadership accelerates global expansion, the stock could outperform peers.
Key entities
- CompanySS Innovations International, Inc.
NASDAQ‑listed developer of surgical robotic technologies.
- ExecutiveDr. Vishwa Srivastava
Promoted to President.
- ExecutiveGary Lo
Appointed Chief Financial Officer.

